ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive

May 10, 1996

DCBDC Board Ok’s New Initiative For Training

November 16, 1990

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

In Brief: Beahrs Headed Team For President’s Surgery; Chiles Chairs HHS Appropriations Subcommittee

January 9, 1987